MedTech News
.................... by Andrew Celentano
AI screening helps more people with diabetes access sight-saving eye care
People receiving AI-supported screening for diabetic retinopathy, a leading cause of blindness globally, were almost twice as likely to attend specialist follow-up appointments as those receiving standard screening, according to new research from the London School of Hygiene & Tropical Medicine (LSHTM).
How a common virus’s hijack of cell repair processes may promote cancer
Most people will become infected with Epstein-Barr virus, or EBV, at some point in their lives. In addition to being a common herpesvirus, EBV persists in its host for life as a “quiet” or latent infection.
Targeted radioactive therapy may help delay spread of recurrent prostate cancer
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
AI tool reveals what attracts immune cells to tumors and what keeps them away
Researchers at The University of Texas MD Anderson Cancer Center and collaborating institutions in Texas developed an artificial intelligence (AI) model that helps explain how immune cells find their way to specific locations in the body and why they avoid others. The findings could help scientists better understand cancer, autoimmune diseases and treatment response.
Emotion-focused AI spots early signs of psychosis in youths from short speech samples
Nanyang Technological University, Singapore (NTU Singapore) and the Institute of Mental Health (IMH) have developed an artificial intelligence (AI) framework capable of identifying youths at high risk of psychosis from short samples of casual, spontaneous speech.
Continuously evolving cells help pancreatic cancer evade treatment and spread
An analysis of nearly half a million cells from dozens of patients’ tumors reveals how cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment for one of the deadliest forms of cancer.
One dose of protein-targeting CAR-T cells shrinks solid tumors in preclinical tests
CAR-T cell therapies have fundamentally transformed the treatment of several blood and lymph node cancers.
Two studies link elevated ear protein levels in blood to tinnitus
When Dr. Kourosh Parham conceived a first-of-its-kind blood test for tinnitus, he knew further research was needed to confirm a link between a unique ear protein and the common hearing disorder. To validate his theory, the professor of surgery at UConn Health (UCH), Division of Otolaryngology-Head & Neck Surgery, teamed up with fellow UCH physician-scientists to conduct two clinical trials.